Abbvie Spending Historic Amount Of Cash To Buy Half Of A Cancer Drug

CHICAGO (TheStreet) -- AbbVie is spending $21 billion to buy half of a cancer drug. That's an extraordinary amount of money even though that cancer drug, Imbruvica, is fantastic and may become one the best-selling of all time. Pharmacyclics developed Imbruvica, which is approved to treat two different types of blood cancer.

BING NEWS:
  • Fed holds rates as it warns fight against inflation has hit a bump
    The world’s largest central bank has warned that its fight against inflation has hit a bump in the road, forcing it to keep interest rates at a 23-year-high. The Federal Reserve’s rate-setters said in ...
    05/1/2024 - 7:17 am | View Link
  • AbbVie retains ad spending leadership, but some surprise drugs make the top 10 in March
    It’s as you were at the top of the pharma drug ad spending list in March as AbbVie ... consistently—and it remains unusual to see any cancer med in these listings, given that it’s not ...
    04/4/2024 - 10:30 pm | View Link
  • Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
    Biotech stocks rose as AbbVie announced plans to buy cancer drug developer ImmunoGen ... AbbVie will pay $31.26 a share in cash for ImmunoGen, a roughly 95% premium to Wednesday's closing price.
    11/30/2023 - 4:30 am | View Link
  • Energy Update: EDF Undercuts Price Cap By £110 With Cheapest Tariff Since 2021
    1 May: Falling Wholesale Prices Feed Through To Consumers Our energy partner, uSwitch, is offering a new 12-month fixed-rate tariff from EDF which is priced at £110 below the regulator Ofgem’s energy ...
    10/13/2021 - 6:40 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News